Skip to main content

Table 1 Baseline characteristics of the study cohort stratified by exposure status

From: The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study

Variable

ESC-S EB index UTI (unexposed)a

ESC-R EB index UTI (exposed)

P value

Demographics

 Age in years (median, IQR)

49 (27–64)

60 (46–70)

<0.01

 Female gender

132 (87%)

108 (72%)

<0.01

 Nonwhite race

81 (54%)

78 (52%)

0.73

 Culture obtained in outpatient clinic

119 (79%)

89 (59%)

<0.01

 Culture obtained in ED

29 (19%)

54 (36%)

<0.01

 Culture obtained within 72 h of inpatient admission

3 (2%)

8 (5%)

0.23

Comorbidities/Exposures

 UTI in prior 6 months

57 (38%)

65 (43%)

0.37

 Urinary catheter

9 (6%)

27 (18%)

<0.01

 Surgery in prior 6 months

21 (14%)

36 (24%)

0.04

 Prostate disease (if male)

6 (32%)

20 (47%)

>0.99

 Liver diseaseb

1 (1%)

8 (5%)

0.04

 Respiratory diseasec

17 (11%)

29 (19%)

0.06

 Diabetes mellitus

14 (9%)

31 (21%)

0.01

 History of hemodialysis

1 (1%)

5 (3%)

0.22

 Malignancy

11 (7%)

28 (19%)

<0.01

 Prior renal transplantation

6 (4%)

13 (8%)

0.11

 Rehabilitation or SNF stay in prior 6 months

3 (2%)

9 (6%)

0.11

 Hospitalization in prior 6 months

35 (23%)

66 (44%)

<0.01

Antibiotic exposuresd

 Any antibiotic

84 (56%)

94 (62%)

0.24

 First-generation cephalosporin

8 (5%)

18 (12%)

0.04

 Extended-spectrum cephalosporin

4 (3%)

19 (13%)

<0.01

 Extended-spectrum penicillin

5 (3%)

12 (8%)

0.07

 Amoxicillin/clavulanate or ampicillin/sulbactam

5 (3%)

11 (7%)

0.11

 Piperacillin-tazobactam

0 (0%)

1 (1%)

>0.99

 Fluoroquinolone

28 (19%)

41 (27%)

0.07

 Aztreonam

0 (0%)

1 (1%)

>0.99

 Carbapenem

1 (1%)

5 (3%)

0.02

 Aminoglycoside

1 (1%)

3 (2%)

0.62

 Nitrofurantoin

26 (17%)

28 (19%)

0.78

 TMP-SMX

19 (13%)

36 (24%)

0.02

 Fosfomycin

1 (1%)

2 (1%)

>0.99

Severity of index UTI

 Pyelonephritis at diagnosis

18 (12%)

44 (29%)

<0.01

 BSI at diagnosis

3 (2%)

6 (4%)

0.51

 Admitted to hospital

12 (8%)

30 (20%)

<0.01

Causative organism of index UTI

Escherichia coli

116 (77%)

112 (74%)

0.59

Klebsiella species

18 (12%)

20 (13%)

0.72

Enterobacter species

12 (8%)

14 (9%)

0.69

Citrobacter species

3 (2%)

1 (1%)

0.63

Proteus species

2 (1%)

4 (3%)

0.69

  1. aData are presented as numbers (percentages) except where noted
  2. bHepatitis or cirrhosis
  3. cCOPD or chronic bronchitis
  4. dReceipt in the 6 months prior to index EB UTI presentation
  5. Abbreviations: BSI bloodstream infection, CI confidence interval, ESC-R extended-spectrum cephalosporin-resistant, ESC-S extended-spectrum cephalosporin-susceptible, ED Emergency Department, IQR interquartile range, SNF skilled nursing facility, TMP-SMX trimethoprim-sulfamethoxazole, UTI urinary tract infection